BACKGROUND: Meat, milk, and eggs have been inconsistently associated with the risk of advanced prostate cancer. These foods are sources of choline-a nutrient that may affect prostate cancer progression through cell membrane function and one-carbon metabolism. No study has examined dietary choline and the risk of lethal prostate cancer. OBJECTIVE: Our objective was to examine whether dietary choline, choline-containing compounds, and betaine (a choline metabolite) increase the risk of lethal prostate cancer. DESIGN: We prospectively examined the intake of these nutrients and the risk of lethal prostate cancer among 47,896 men in the Health Professionals Follow-Up Study. In a case-only survival analysis, we examined the postdiagnostic intake of these nutrients and the risk of lethal prostate cancer among 4282 men with an initial diagnosis of nonmetastatic disease during follow-up. Diet was assessed with a validated questionnaire 6 times during 22 y of follow-up. RESULTS: In the incidence analysis, we observed 695 lethal prostate cancers during 879,627 person-years. Men in the highest quintile of choline intake had a 70% increased risk of lethal prostate cancer (HR: 1.70; 95% CI: 1.18, 2.45; P-trend = 0.005). In the case-only survival analysis, we observed 271 lethal cases during 33,679 person-years. Postdiagnostic choline intake was not statistically significantly associated with the risk of lethal prostate cancer (HR for quintile 5 compared with quintile 1: 1.69; 95% CI: 0.93, 3.09; P-trend = 0.20). CONCLUSION: Of the 47,896 men in our study population, choline intake was associated with an increased risk of lethal prostate cancer.
BACKGROUND: Meat, milk, and eggs have been inconsistently associated with the risk of advanced prostate cancer. These foods are sources of choline-a nutrient that may affect prostate cancer progression through cell membrane function and one-carbon metabolism. No study has examined dietary choline and the risk of lethal prostate cancer. OBJECTIVE: Our objective was to examine whether dietary choline, choline-containing compounds, and betaine (a choline metabolite) increase the risk of lethal prostate cancer. DESIGN: We prospectively examined the intake of these nutrients and the risk of lethal prostate cancer among 47,896 men in the Health Professionals Follow-Up Study. In a case-only survival analysis, we examined the postdiagnostic intake of these nutrients and the risk of lethal prostate cancer among 4282 men with an initial diagnosis of nonmetastatic disease during follow-up. Diet was assessed with a validated questionnaire 6 times during 22 y of follow-up. RESULTS: In the incidence analysis, we observed 695 lethal prostate cancers during 879,627 person-years. Men in the highest quintile of choline intake had a 70% increased risk of lethal prostate cancer (HR: 1.70; 95% CI: 1.18, 2.45; P-trend = 0.005). In the case-only survival analysis, we observed 271 lethal cases during 33,679 person-years. Postdiagnostic choline intake was not statistically significantly associated with the risk of lethal prostate cancer (HR for quintile 5 compared with quintile 1: 1.69; 95% CI: 0.93, 3.09; P-trend = 0.20). CONCLUSION: Of the 47,896 men in our study population, choline intake was associated with an increased risk of lethal prostate cancer.
Authors: Kathryn M Wilson; Julie L Kasperzyk; Jennifer R Rider; Stacey Kenfield; Rob M van Dam; Meir J Stampfer; Edward Giovannucci; Lorelei A Mucci Journal: J Natl Cancer Inst Date: 2011-05-17 Impact factor: 13.506
Authors: Nada M S Al-Saffar; L Elizabeth Jackson; Florence I Raynaud; Paul A Clarke; Ana Ramírez de Molina; Juan C Lacal; Paul Workman; Martin O Leach Journal: Cancer Res Date: 2010-06-15 Impact factor: 12.701
Authors: Jane C Figueiredo; Maria V Grau; Robert W Haile; Robert S Sandler; Robert W Summers; Robert S Bresalier; Carol A Burke; Gail E McKeown-Eyssen; John A Baron Journal: J Natl Cancer Inst Date: 2009-03-10 Impact factor: 13.506
Authors: Mattias Johansson; Bethany Van Guelpen; Stein Emil Vollset; Johan Hultdin; Anders Bergh; Tim Key; Oivind Midttun; Göran Hallmans; Per M Ueland; Pär Stattin Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-05 Impact factor: 4.254
Authors: Erin L Richman; Meir J Stampfer; Alan Paciorek; Jeanette M Broering; Peter R Carroll; June M Chan Journal: Am J Clin Nutr Date: 2009-12-30 Impact factor: 7.045
Authors: Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce S Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen Journal: Nature Date: 2011-04-07 Impact factor: 49.962
Authors: Kana Wu; Donna Spiegelman; Tao Hou; Demetrius Albanes; Naomi E Allen; Sonja I Berndt; Piet A van den Brandt; Graham G Giles; Edward Giovannucci; R Alexandra Goldbohm; Gary G Goodman; Phyllis J Goodman; Niclas Håkansson; Manami Inoue; Timothy J Key; Laurence N Kolonel; Satu Männistö; Marjorie L McCullough; Marian L Neuhouser; Yikyung Park; Elizabeth A Platz; Jeannette M Schenk; Rashmi Sinha; Meir J Stampfer; Victoria L Stevens; Shoichiro Tsugane; Kala Visvanathan; Lynne R Wilkens; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner Journal: Int J Cancer Date: 2016-05-15 Impact factor: 7.396
Authors: Peijin Han; Aurelian Bidulescu; John R Barber; Steven H Zeisel; Corinne E Joshu; Anna E Prizment; Mara Z Vitolins; Elizabeth A Platz Journal: Cancer Causes Control Date: 2019-03-01 Impact factor: 2.506
Authors: Chad A Reichard; Bryan D Naelitz; Zeneng Wang; Xun Jia; Jianbo Li; Meir J Stampfer; Eric A Klein; Stanley L Hazen; Nima Sharifi Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-10-28 Impact factor: 4.090
Authors: Sam F Peisch; Erin L Van Blarigan; June M Chan; Meir J Stampfer; Stacey A Kenfield Journal: World J Urol Date: 2016-08-12 Impact factor: 4.226
Authors: E Susan Amirian; Joseph F Petrosino; Nadim J Ajami; Yanhong Liu; Martha P Mims; Michael E Scheurer Journal: Infect Agent Cancer Date: 2013-11-04 Impact factor: 2.965